|
Real-time Estimate
Cboe BZX
17:49:22 01/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 259.04 USD | +1.02% |
|
-1.51% | +14.57% |
| 03:51pm | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 08-27 | AbbVie Seeks EU Approval for Subcutaneous Skyrizi Induction in Crohn's Disease | MT |
| Market Cap | 453B 390B 366B 334B 628B 43,114B 633B 4,341B 1,689B 21,863B 1,701B 1,664B 72,390B | P/E 2026 * |
32.7x | P/E 2027 * | 24.2x |
|---|---|---|---|---|---|
| Enterprise Value | 514B 442B 415B 379B 712B 48,870B 717B 4,920B 1,914B 24,781B 1,928B 1,887B 82,054B | EV / Sales 2026 * |
7.6x | EV / Sales 2027 * | 6.87x |
| Free-Float |
95.71% | Yield 2026 * |
2.67% | Yield 2027 * | 2.81% |
Last Transcript : AbbVie Inc.
| 1 day | +1.42% | ||
| 1 week | -3.06% | ||
| 1 month | +2.18% | ||
| 3 months | +17.78% | ||
| 6 months | +10.49% | ||
| Current year | +12.22% |
| 1 week | 252.33 |  | 265 |
| 1 month | 241.2 | | 266.96 |
| Current year | 190.75 | | 267.47 |
| 1 year | 190.75 | | 267.47 |
| 3 years | 135.85 | | 267.47 |
| 5 years | 105.56 | | 267.47 |
| 10 years | 55.06 | | 267.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 23/06/2022 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 74 | 01/01/2013 |
Ed Rapp
BRD | Director/Board Member | 69 | 01/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/26 | Exercice | Executive/Senior Manager | 98,130 | 0.0056% | ||
| 30/06/26 | Free | Director | 62 | 0.0000% | ||
| 30/06/26 | Free | Director | 134 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.38% | -3.06% | +21.87% | +74.48% | 453B | |
| +1.49% | -7.23% | +57.90% | +108.72% | 1,031B | |
| +1.27% | -2.63% | +50.05% | +64.43% | 641B | |
| -1.32% | -5.91% | +33.94% | +33.88% | 349B | |
| +6.18% | +3.61% | +29.35% | +47.06% | 290B | |
| +0.27% | -0.59% | +1.59% | +12.91% | 252B | |
| +0.53% | -3.15% | +49.83% | +67.70% | 232B | |
| +1.49% | -1.47% | -19.24% | -53.71% | 201B | |
| +0.90% | -0.27% | +29.84% | +91.34% | 181B | |
| +1.37% | +1.75% | +14.94% | -19.56% | 162B | |
| Average | +1.47% | -2.50% | +27.01% | +42.73% | 379.2B | |
| Weighted average by Cap. | +1.50% | -3.73% | +36.38% | +61.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.58B 58.19B 54.64B 49.88B 93.7B 6,431B 94.37B 647B 252B 3,261B 254B 248B 10,797B | 73.52B 63.3B 59.44B 54.26B 102B 6,995B 103B 704B 274B 3,547B 276B 270B 11,745B |
| Net income | 13.86B 11.93B 11.21B 10.23B 19.22B 1,319B 19.36B 133B 51.67B 669B 52.05B 50.92B 2,214B | 18.91B 16.28B 15.29B 13.96B 26.22B 1,800B 26.41B 181B 70.5B 913B 71.02B 69.47B 3,022B |
| Net Debt | 60.49B 52.08B 48.9B 44.64B 83.86B 5,756B 84.46B 579B 225B 2,919B 227B 222B 9,664B | 51.66B 44.48B 41.77B 38.12B 71.62B 4,916B 72.13B 495B 193B 2,493B 194B 190B 8,253B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | $261.83 | +2.11% | 128,494 |
| 31/08/26 | $256.42 | +0.37% | 4,315,487 |
| 28/08/26 | $255.48 | -1.03% | 3,224,862 |
| 27/08/26 | $258.15 | -1.81% | 4,764,797 |
| 26/08/26 | $262.90 | -1.09% | 3,308,871 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
